Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for type 2 diabetes and weight management, and exposure to elevated temperatures during shipping may compromise its therapeutic properties
Third, and for the same reason(s), any observed deficit in GLP-1 responses after meals does not simply call for a true replacement therapy with incretin-based glucose-lowering medications
Fujita N, Sugimoto R, Takeo M, Urawa N, Mifuji R, Tanaka H, et al
Common Side Effects Injection site reactions represent the most frequently reported side effects
The most important thing is to communicate with your doctor or pharmacist rather than just stopping treatment or suffering through it, Dr